Aurora Cannabis Inc.
TSX:ACB.TODrug Manufacturers - Specialty & Generic
+$0.02 today
- Market cap
- $414.85M
- Beta
- 1.34
- P/E (TTM)
- -3.2
- EPS (TTM)
- -$1.31
Volume 0.32M
Average 0.42M
ACB.TO Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Aurora Cannabis Inc.TSX: ACB.TO
Capital Expenditures · Q4 FY2026 · quarter ended Mar 2026
Capital expenditures grows in line with its trailing trend
Q4 FY2026 capital expenditures of CA$5.17M (cash outflow) rose 20.2% year over year, ahead of the +19.5% change in trailing-twelve-month capital expenditures. Sequentially, it fell 13.5% from the prior quarter. Over 3 fiscal years it compounded at +22.9% a year.
Context
- Capital expenditures amounted to 7.0% of revenue in FY2026, up 1.5 pp from a year earlier.
- Capital expenditures grew in size in 3 of the last 3 fiscal years.
- FY2026 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +20.2% holds above the trailing-twelve-month pace of +19.5%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
CAD · from the cash flow
- Latest · FY2026
- (22.55M) CAD
- Year-over-year change
- -19.5%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2026 | 2026-03-31 | (22.55M) | -19.5% |
| FY2025 | 2025-03-31 | (18.86M) | -11.2% |
| FY2024 | 2024-03-31 | (16.96M) | -39.8% |
| FY2023 | 2023-03-31 | (12.13M) | +62.3% |
| FY2022 | 2022-06-30 | (32.21M) | — |
Capital Expenditures vs competitors
How ACB.TO compares with its peers on the latest reported figures
- Peers report in different currencies, so capital expenditures is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +19.5% is the 4th highest of 7, against a peer median of +15.4%.
- Capital expenditures amounts to 7.1% of revenue for ACB.TO, versus a peer median of 2.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | CA$22.55M CAD | +19.5% | +22.9% | 7.1% | |
| LTM Mar 2026 | CA$11.19M CAD | +1.5% | — | 4.1% | |
| LTM Mar 2026 | $6.87M USD | -37.4% | -45.7% | 2.6% | |
| LTM Mar 2026 | CA$6.44M CAD | -42.9% | -17.4% | 2.1% | |
| LTM Mar 2026 | CA$3.26M CAD | +29.2% | -35.1% | 2.1% | |
| LTM Mar 2026 | $107.42K USD | +168.5% | -29.4% | 0.2% | |
| LTM Mar 2026 | CA$28K CAD | +154.5% | +80.8% | 1.0% | |
| LTM Mar 2026 | $3.64 USD | — | — | 0.0% | |
| Peer median (excluding ACB.TO) | — | +15.4% | -29.4% | 2.1% | |
Competitors are the stored peer set for ACB.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Jun 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 | FY2026 Mar 2026 |
|---|---|---|---|---|---|
| Net Income | (1.72B) | (265.33M) | (59.05M) | 15.76M | (58.62M) |
| Depreciation & Amortization | 93.66M | 43.57M | 33.07M | 22.55M | 14.19M |
| Deferred Income Tax | (2.19M) | (18.4M) | (1.67M) | (3.19M) | 55K |
| Stock-Based Compensation | 13.76M | 16.89M | 12.72M | 11.52M | 7.29M |
| Change in Working Capital | 52.65M | (25.12M) | (15.63M) | 10.21M | (9.21M) |
| Accounts Receivables | 18.34M | 5.53M | (4.33M) | 5.24M | (8.15M) |
| Inventory | 21.07M | 49.03M | 3.62M | (15.05M) | 7.44M |
| Accounts Payables | 6.77M | (8.06M) | (15.7M) | 14.91M | (8.04M) |
| Other Working Capital | 6.48M | (71.61M) | 790K | 5.11M | (9.21M) |
| Other Non-Cash Items | 1.45B | 190.11M | (37.96M) | (40.85M) | 54.32M |
| Operating Cash Flow | (110.27M) | (115.82M) | (68.51M) | 16.01M | (13.51M) |
| Capital Expenditures | (32.21M) | (12.13M) | (16.96M) | (18.86M) | (22.55M) |
| Acquisitions (Net) | (23.42M) | (18.54M) | (5.55M) | 0 | 1.1M |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 3.36M | 4.99M | 5.49M | 0 |
| Other Investing Activities | 19.46M | 16K | 12.02M | (956K) | (51.98M) |
| Investing Cash Flow | (36.17M) | (27.29M) | (5.49M) | (14.33M) | (73.43M) |
| Debt Repayment | (170.83M) | — | (85.76M) | (805K) | (5.02M) |
| Common Stock Issued | 350.19M | 73.19M | 37.93M | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (31.58M) | (95.21M) | (89K) | 689K | (154K) |
| Financing Cash Flow | 147.78M | (56.48M) | (47.92M) | (116K) | 9.76M |
| Effect of Forex Changes | 15.01M | 15.54M | 297K | 264K | 4.33M |
| Net Change in Cash | 16.35M | (140.01M) | (121.5M) | 1.83M | (72.85M) |
| Free Cash Flow | (142.48M) | (127.95M) | (85.46M) | (2.85M) | (36.06M) |
Aurora Cannabis Inc.
TSX:ACB.TO
Intrinsic Alpha fair value
Locked
Current Price
$6.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.